Filter
2912
Filtered Results: 2912
Text search:
maladie
Featured
Recommendations
237
New Publications
492
Language
Document type
No document type
1149
Studies & Reports
571
Guidelines
451
Fact sheets
201
Strategic & Response Plan
148
Manuals
106
Infographics
69
Training Material
62
Resource Platforms
35
Online Courses
29
Brochures
28
Situation Updates
28
Videos
23
Dashboards/Maps
11
App
1
Countries / Regions
Global
445
Congo, Democratic Republic of
201
Senegal
181
Burkina Faso
130
Africa
118
Benin
93
Guinea
78
Haiti
71
West and Central Africa
56
Mali
55
Cameroon
50
Côte d’Ivoire / Ivory Coast
46
Latin America and the Carribbean
45
Central African Republic
39
Madagascar
37
Rwanda
33
Niger
29
East and Southern Africa
23
Chad
23
Middle East and North Africa
20
Western and Central Europe
19
North America
19
Togo
16
South Africa
16
India
16
Germany
14
South–East Asia Region
14
Eastern Europe
12
Ukraine
10
Asia
9
France
9
Brazil
8
Ethiopia
8
Congo-Brazzaville
7
Burundi
7
Luxembourg
7
Russia
7
Liberia
7
Sierra Leone
6
Syria
6
Malawi
6
Mozambique
6
Canada
5
Morocco
5
USA
5
Bolivia
5
Angola
5
Somalia
5
Colombia
4
Kenya
4
Nigeria
4
Western Pacific Region
4
Eastern Europe and Central Asia
4
Belgium
4
Yemen
4
Zimbabwe
3
Cambodia
3
Guinea-Bissau
3
Bangladesh
3
Uganda
3
Djibouti
3
South Sudan
3
Nepal
2
Switzerland
2
Thailand
2
Mexico
2
Ghana
2
China
2
Afghanistan
2
Mauritania
2
Tanzania
2
Saudi Arabia
2
Tunisia
2
Algeria
2
Argentina
2
Namibia
2
Zambia
2
Iraq
2
Ecuador
2
Timor Leste/ East Timor
1
Turkey
1
Singapore
1
Peru
1
Austria
1
Venezuela
1
Jordan
1
Gabon
1
Uruguay
1
Jamaica
1
United Kingdom
1
Southern Africa
1
Barbados
1
United Arab Emirates
1
Vietnam
1
Sri Lanka
1
Egypt
1
Sudan
1
Georgia
1
Poland
1
Libya
1
Botswana
1
Bahamas
1
Pakistan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Public Health
811
Countries
810
Clinical Guidelines
458
Women & Child Health
124
Key Resources
81
Capacity Building
61
Pharmacy & Technologies
29
Toolboxes
NCDs
568
COVID-19
315
Ebola
187
Rapid Response
162
Mental Health
135
NTDs
94
Caregiver
78
TB
70
HIV
52
Cholera
51
Disability
50
Refugee
45
AMR
39
Planetary Health
34
Zika
32
Pharmacy
26
Polio
22
Natural Hazards
16
Conflict
14
Global Health Education
12
Social Ethics
10
Health Financing Toolbox
5
Specific Hazards
2
Typhoon
1
Chagas disease is a tropical parasitic infection transmitted by crawling, blood-sucking insects (kissing bugs). You may have flu-like symptoms or none at all. But the disease can lead to life-threatening complications. With prompt treatment, most people with Chagas disease, also known as American tr...
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is
found mainly in endemic areas of 21 Latin American countries. Chagas disease was once entirely
...
Chagas disease is caused by Trypanosoma cruzi, a protozoal organism primarily transmitted by triatomine insect vectors, also known as “kissing bugs.” It is a zoonotic disease originally described by Brazilian physician Dr. Carlos Chagas in 1909 and is widespread in Latin America. Although triato...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Chagas disease (CD) is endemic in the Americas, being present in 21 countries, where it affects about 6 million
people.(1) With such relevant numbers of people affected and disability adjusted life years lost, CD is a poverty-related
and poverty-promoting disease.
Although data describe a relevan...
DOI: 10.5772/intechopen.102891Little progress has been made since the 1960s and 19. 70s to widen the therapeutic arsenal against Trypanosoma cruzi, the causative pathogen of Chagas disease, which remains a frustrating and perplexing infectious disease. This chapter focuses on the strategic and opera...
This review focusses on the interactions between the etiologic agent of Chagas disease, Trypanosoma cruzi, and its triatomine vector. The flagellate mainly colonizes the intestinal tract of the insect. The effect of triatomines on trypanosomes is indicated by susceptibility and refractoriness phenom...
Coherent Market Insights has announced the addition of Chagas Disease Treatment Market 2023 Forecast Analysis by Types, Applications, Size, Share, Key Players, and Regions. a new research report to its market research archive. The Chagas Disease Treatment Market has been thoroughly researched and an...
El desarrollo, desde 1991, de las Iniciativas Subregionales de Control de la Enfermedad de Chagas, y los avances de conocimiento en materia de diagnóstico y manejo de la infección/enfermedad de Chagas, llevan a la necesidad ética, y operativamente imperiosa, de estructurar el diagnóstico, atenci...
The document titled "Cómo combatir el cólera" (How to Combat Cholera) provides comprehensive guidelines on the clinical presentation and management of cholera, particularly in the context of the 2010 Haiti outbreak.
It emphasizes the importance of rapid rehydration as a lifesaving measure, deta...
The intention of this handbook on integrated vector management (IVM) is to provide
guidance to the managers of vector-borne disease control programmes, including
comparable officials in health and other sectors involved in vector-borne disease control.
The target audience is managers and official...
Biology, Diagnosis and Treatment, Epidemiology and Prevention
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Prevention Of Cardiovascular Disease: Guidelines For Assessment And Management Or Cardiocascular Risk
recommended
This publication provides guidance on reducing disability and premature deaths from coronary heart disease, cerebrovascular disease and peripheral vascular disease in people at high risk, who have not yet experienced a cardiovascular event.
Prevention of Cardiovascular Disease. Pocket Guidelines for Assessment and Management of Cardiovascular Risk
recommended
These pocket guidelines provide evidence-based guidance on how to reduce the incidence of first and recurrent clinical events due to coronary heart disease (CHD), cerebrovascular disease (CeVD) and peripheral vascular disease in two categories of people
Cancer, diabetes, heart disease and stroke, chronic respiratory disease
Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced medical students.
